[1]
Johnson JR, Russo TA. Acute Pyelonephritis in Adults. The New England journal of medicine. 2018 Jan 4:378(1):48-59
[PubMed PMID: 29298155]
[2]
Guarino N, Casamassima MG, Tadini B, Marras E, Lace R, Bianchi M. Natural history of vesicoureteral reflux associated with kidney anomalies. Urology. 2005 Jun:65(6):1208-11
[PubMed PMID: 15913724]
[4]
Ciccarese F, Brandi N, Corcioni B, Golfieri R, Gaudiano C. Complicated pyelonephritis associated with chronic renal stone disease. La Radiologia medica. 2021 Apr:126(4):505-516. doi: 10.1007/s11547-020-01315-7. Epub 2020 Nov 27
[PubMed PMID: 33245481]
[5]
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature reviews. Microbiology. 2015 May:13(5):269-84. doi: 10.1038/nrmicro3432. Epub 2015 Apr 8
[PubMed PMID: 25853778]
[6]
Choong FX, Antypas H, Richter-Dahlfors A. Integrated Pathophysiology of Pyelonephritis. Microbiology spectrum. 2015 Oct:3(5):. doi: 10.1128/microbiolspec.UTI-0014-2012. Epub
[PubMed PMID: 26542040]
[8]
Pasiechnikov S, Buchok O, Sheremeta R, Banyra O. Empirical treatment in patients with acute obstructive pyelonephritis. Infectious disorders drug targets. 2015:15(3):163-70
[PubMed PMID: 26321323]
[10]
Keren R, Shaikh N, Pohl H, Gravens-Mueller L, Ivanova A, Zaoutis L, Patel M, deBerardinis R, Parker A, Bhatnagar S, Haralam MA, Pope M, Kearney D, Sprague B, Barrera R, Viteri B, Egigueron M, Shah N, Hoberman A. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring. Pediatrics. 2015 Jul:136(1):e13-21. doi: 10.1542/peds.2015-0409. Epub 2015 Jun 8
[PubMed PMID: 26055855]
[11]
Graversen ME, Dalgaard LS, Jensen-Fangel S, Jespersen B, Østergaard L, Søgaard OS. Risk and outcome of pyelonephritis among renal transplant recipients. BMC infectious diseases. 2016 Jun 10:16():264. doi: 10.1186/s12879-016-1608-x. Epub 2016 Jun 10
[PubMed PMID: 27287058]
[14]
Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, Sugar AM, Sharkey PK, Wise GJ, Mangi R, Mosher A, Lee JY, Dismukes WE. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2000 Jan:30(1):14-8
[PubMed PMID: 10619726]
[15]
Alvarez-Lerma F, Nolla-Salas J, León C, Palomar M, Jordá R, Carrasco N, Bobillo F, EPCAN Study Group. Candiduria in critically ill patients admitted to intensive care medical units. Intensive care medicine. 2003 Jul:29(7):1069-76
[PubMed PMID: 12756441]
[16]
Colodner R, Nuri Y, Chazan B, Raz R. Community-acquired and hospital-acquired candiduria: comparison of prevalence and clinical characteristics. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2008 Apr:27(4):301-5
[PubMed PMID: 18097694]
[17]
Bougnoux ME, Kac G, Aegerter P, d'Enfert C, Fagon JY, CandiRea Study Group. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive care medicine. 2008 Feb:34(2):292-9
[PubMed PMID: 17909746]
[18]
Irby PB, Stoller ML, McAninch JW. Fungal bezoars of the upper urinary tract. The Journal of urology. 1990 Mar:143(3):447-51
[PubMed PMID: 2304151]
[19]
Das MK, Rangrajan Pakshi R, Kalra S, Elumalai A, Theckumparampil N. Fungal Balls Mimicking Renal Calculi: A Zebra Among Horses. Journal of endourology case reports. 2019:5(4):167-170. doi: 10.1089/cren.2019.0012. Epub 2019 Dec 2
[PubMed PMID: 32775655]
Level 3 (low-level) evidence
[20]
Talan DA,Takhar SS,Krishnadasan A,Abrahamian FM,Mower WR,Moran GJ,EMERGEncy ID Net Study Group., Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, United States(1). Emerging infectious diseases. 2016 Sep
[PubMed PMID: 27532362]
[21]
Zilberberg MD, Shorr AF. Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009. Infection control and hospital epidemiology. 2013 Sep:34(9):940-6. doi: 10.1086/671740. Epub 2013 Jul 25
[PubMed PMID: 23917908]
[22]
Lautenbach E. Editorial commentary: flying under the radar: the stealth pandemic of Escherichia coli sequence type 131. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013 Nov:57(9):1266-9. doi: 10.1093/cid/cit505. Epub 2013 Aug 6
[PubMed PMID: 23926177]
Level 3 (low-level) evidence
[23]
Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR, VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013 Nov:57(9):1256-65. doi: 10.1093/cid/cit503. Epub 2013 Aug 6
[PubMed PMID: 23926176]
[24]
Khawcharoenporn T, Vasoo S, Singh K. Urinary Tract Infections due to Multidrug-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Chicago Emergency Department. Emergency medicine international. 2013:2013():258517. doi: 10.1155/2013/258517. Epub 2013 Oct 31
[PubMed PMID: 24307946]
[25]
Killgore KM, March KL, Guglielmo BJ. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. The Annals of pharmacotherapy. 2004 Jul-Aug:38(7-8):1148-52
[PubMed PMID: 15150380]
[26]
Walker E, Lyman A, Gupta K, Mahoney MV, Snyder GM, Hirsch EB. Clinical Management of an Increasing Threat: Outpatient Urinary Tract Infections Due to Multidrug-Resistant Uropathogens. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016 Oct 1:63(7):960-5. doi: 10.1093/cid/ciw396. Epub 2016 Jun 16
[PubMed PMID: 27313263]
[27]
Smithson A, Chico C, Ramos J, Netto C, Sanchez M, Ruiz J, Porron R, Bastida MT. Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2012 Apr:31(4):423-30. doi: 10.1007/s10096-011-1322-y. Epub 2011 Jul 15
[PubMed PMID: 21761126]
[29]
Trautner BW, Kaye KS, Gupta V, Mulgirigama A, Mitrani-Gold FS, Scangarella-Oman NE, Yu K, Ye G, Joshi AV. Risk Factors Associated With Antimicrobial Resistance and Adverse Short-Term Health Outcomes Among Adult and Adolescent Female Outpatients With Uncomplicated Urinary Tract Infection. Open forum infectious diseases. 2022 Dec:9(12):ofac623. doi: 10.1093/ofid/ofac623. Epub 2022 Nov 21
[PubMed PMID: 37065971]
[30]
Mitrani-Gold FS, Kaye KS, Gupta V, Mulgirigama A, Trautner BW, Scangarella-Oman NE, Yu KC, Ye G, Joshi AV. Older patient age and prior antimicrobial use strongly predict antimicrobial resistance in Escherichia coli isolates recovered from urinary tract infections among female outpatients. PloS one. 2023:18(5):e0285427. doi: 10.1371/journal.pone.0285427. Epub 2023 May 11
[PubMed PMID: 37167277]
[31]
Chen Q, Li D, Beiersmann C, Neuhann F, Moazen B, Lu G, Müller O. Risk factors for antibiotic resistance development in healthcare settings in China: a systematic review. Epidemiology and infection. 2021 Jun 3:149():e141. doi: 10.1017/S0950268821001254. Epub 2021 Jun 3
[PubMed PMID: 34078502]
Level 1 (high-level) evidence
[32]
Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE, Infectious Diseases Society of America, European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011 Mar 1:52(5):e103-20. doi: 10.1093/cid/ciq257. Epub
[PubMed PMID: 21292654]
Level 1 (high-level) evidence
[33]
Wagenlehner FM, Sobel JD, Newell P, Armstrong J, Huang X, Stone GG, Yates K, Gasink LB. Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016 Sep 15:63(6):754-762. doi: 10.1093/cid/ciw378. Epub 2016 Jun 16
[PubMed PMID: 27313268]
Level 1 (high-level) evidence
[35]
Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrobial resistance and infection control. 2017:6():47. doi: 10.1186/s13756-017-0208-x. Epub 2017 May 15
[PubMed PMID: 28515903]
[36]
Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Therapeutic advances in urology. 2019 Jan-Dec:11():1756287219832172. doi: 10.1177/1756287219832172. Epub 2019 May 2
[PubMed PMID: 31105774]
Level 3 (low-level) evidence
[37]
Jansåker F, Li X, Vik I, Frimodt-Møller N, Knudsen JD, Sundquist K. The Risk of Pyelonephritis Following Uncomplicated Cystitis: A Nationwide Primary Healthcare Study. Antibiotics (Basel, Switzerland). 2022 Nov 24:11(12):. doi: 10.3390/antibiotics11121695. Epub 2022 Nov 24
[PubMed PMID: 36551352]
[38]
Foxman B, Klemstine KL, Brown PD. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Annals of epidemiology. 2003 Feb:13(2):144-50
[PubMed PMID: 12559674]
[39]
Svingel LS, Christiansen CF, Birn H, Søgaard KK, Nørgaard M. Temporal changes in incidence of hospital-diagnosed acute pyelonephritis: A 19-year population-based Danish cohort study. IJID regions. 2023 Dec:9():104-110. doi: 10.1016/j.ijregi.2023.10.003. Epub 2023 Oct 12
[PubMed PMID: 38020186]
[40]
Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007 Aug 1:45(3):273-80
[PubMed PMID: 17599303]
[41]
Ansaldi Y, Martinez de Tejada Weber B. Urinary tract infections in pregnancy. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2023 Oct:29(10):1249-1253. doi: 10.1016/j.cmi.2022.08.015. Epub 2022 Aug 27
[PubMed PMID: 36031053]
[42]
Angelescu K, Nussbaumer-Streit B, Sieben W, Scheibler F, Gartlehner G. Benefits and harms of screening for and treatment of asymptomatic bacteriuria in pregnancy: a systematic review. BMC pregnancy and childbirth. 2016 Nov 2:16(1):336
[PubMed PMID: 27806709]
Level 1 (high-level) evidence
[43]
Kazemier BM, Koningstein FN, Schneeberger C, Ott A, Bossuyt PM, de Miranda E, Vogelvang TE, Verhoeven CJ, Langenveld J, Woiski M, Oudijk MA, van der Ven JE, Vlegels MT, Kuiper PN, Feiertag N, Pajkrt E, de Groot CJ, Mol BW, Geerlings SE. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. The Lancet. Infectious diseases. 2015 Nov:15(11):1324-33. doi: 10.1016/S1473-3099(15)00070-5. Epub 2015 Aug 5
[PubMed PMID: 26255208]
Level 1 (high-level) evidence
[44]
Ruiz-Rosado JD, Robledo-Avila F, Cortado H, Rangel-Moreno J, Justice SS, Yang C, Spencer JD, Becknell B, Partida-Sanchez S. Neutrophil-Macrophage Imbalance Drives the Development of Renal Scarring during Experimental Pyelonephritis. Journal of the American Society of Nephrology : JASN. 2021 Jan:32(1):69-85. doi: 10.1681/ASN.2020030362. Epub 2020 Nov 4
[PubMed PMID: 33148615]
[45]
Li B, Haridas B, Jackson AR, Cortado H, Mayne N, Kohnken R, Bolon B, McHugh KM, Schwaderer AL, Spencer JD, Ching CB, Hains DS, Justice SS, Partida-Sanchez S, Becknell B. Inflammation drives renal scarring in experimental pyelonephritis. American journal of physiology. Renal physiology. 2017 Jan 1:312(1):F43-F53. doi: 10.1152/ajprenal.00471.2016. Epub 2016 Oct 19
[PubMed PMID: 27760770]
[46]
Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD Atlas of Renal Pathology: Acute Pyelonephritis. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2016 Oct:68(4):e21-e22. doi: 10.1053/j.ajkd.2016.08.004. Epub
[PubMed PMID: 27664480]
[47]
Khoo KSM, Lim ZY, Chai CY, Mahadevan M, Kuan WS. Management of acute pyelonephritis in the emergency department observation unit. Singapore medical journal. 2021 Jun:62(6):287-295. doi: 10.11622/smedj.2020020. Epub 2020 Mar 9
[PubMed PMID: 32147739]
[48]
. Urinary Tract Infections in Pregnant Individuals. Obstetrics and gynecology. 2023 Aug 1:142(2):435-445. doi: 10.1097/AOG.0000000000005269. Epub
[PubMed PMID: 37473414]
[49]
Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R. Are blood cultures necessary in the management of women with complicated pyelonephritis? The Journal of infection. 2006 Oct:53(4):235-40
[PubMed PMID: 16434102]
[50]
Papava V, Didbaridze T, Zaalishvili Z, Gogokhia N, Maziashvili G. The Role of Urinary Nitrite in Predicting Bacterial Resistance in Urine Culture Analysis Among Patients With Uncomplicated Urinary Tract Infection. Cureus. 2022 Jun:14(6):e26032. doi: 10.7759/cureus.26032. Epub 2022 Jun 17
[PubMed PMID: 35865430]
[51]
Arambašić J, Mandić S, Debeljak Ž, Mandić D, Horvat V, Šerić V. Differentiation of acute pyelonephritis from other febrile states in children using urinary neutrophil gelatinase-associated lipocalin (uNGAL). Clinical chemistry and laboratory medicine. 2016 Jan:54(1):55-61. doi: 10.1515/cclm-2015-0377. Epub
[PubMed PMID: 26053013]
[52]
Moon JH, Yoo KH, Yim HE. Urinary neutrophil gelatinase-associated lipocalin: a marker of urinary tract infection among febrile children. Clinical and experimental pediatrics. 2021 Jul:64(7):347-354. doi: 10.3345/cep.2020.01130. Epub 2020 Oct 17
[PubMed PMID: 33091975]
[53]
Yamamoto A, Nakayama S, Wakabayashi Y, Yoshino Y, Kitazawa T. Urine neutrophil gelatinase-associated lipocalin as a biomarker of adult pyelonephritis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023 May:29(5):508-512. doi: 10.1016/j.jiac.2023.01.001. Epub 2023 Jan 5
[PubMed PMID: 36621764]
[54]
Shaikh K, Rajakumar V, Osio VA, Shaikh N. Neutrophil gelatinase-associated lipocalin for urinary tract infection and pyelonephritis: a systematic review. Pediatric nephrology (Berlin, Germany). 2021 Jun:36(6):1481-1487. doi: 10.1007/s00467-020-04854-3. Epub 2021 Jan 3
[PubMed PMID: 33389090]
Level 1 (high-level) evidence
[56]
Gürol G, Çiftci İH, Terizi HA, Atasoy AR, Ozbek A, Köroğlu M. Are there standardized cutoff values for neutrophil-lymphocyte ratios in bacteremia or sepsis? Journal of microbiology and biotechnology. 2015 Apr:25(4):521-5
[PubMed PMID: 25341467]
[57]
Martins EC, Silveira LDF, Viegas K, Beck AD, Fioravantti Júnior G, Cremonese RV, Lora PS. Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: a case-control study. Revista Brasileira de terapia intensiva. 2019:31(1):64-70. doi: 10.5935/0103-507X.20190010. Epub 2019 Mar 21
[PubMed PMID: 30916236]
Level 2 (mid-level) evidence
[60]
Expert Panel on Urological Imaging, Smith AD, Nikolaidis P, Khatri G, Chong ST, De Leon AD, Ganeshan D, Gore JL, Gupta RT, Kwun R, Lyshchik A, Nicola R, Purysko AS, Savage SJ, Taffel MT, Yoo DC, Delaney EW, Lockhart ME. ACR Appropriateness Criteria® Acute Pyelonephritis: 2022 Update. Journal of the American College of Radiology : JACR. 2022 Nov:19(11S):S224-S239. doi: 10.1016/j.jacr.2022.09.017. Epub
[PubMed PMID: 36436954]
[61]
Yu J, Sri-Ganeshan M, Smit V, Mitra B. Ultrasound for acute pyelonephritis: a systematic review and meta-analysis. Internal medicine journal. 2024 Feb 9:():. doi: 10.1111/imj.16347. Epub 2024 Feb 9
[PubMed PMID: 38339768]
Level 1 (high-level) evidence
[62]
Pinto DS, George A, Johny J, Hoisala RV. Role of MRI in the evaluation of acute pyelonephritis in a high-risk population with renal dysfunction: a prospective study. Emergency radiology. 2023 Jun:30(3):285-295. doi: 10.1007/s10140-023-02122-z. Epub 2023 Mar 24
[PubMed PMID: 36959518]
[63]
El-Ghar MA, Farg H, Sharaf DE, El-Diasty T. CT and MRI in Urinary Tract Infections: A Spectrum of Different Imaging Findings. Medicina (Kaunas, Lithuania). 2021 Jan 1:57(1):. doi: 10.3390/medicina57010032. Epub 2021 Jan 1
[PubMed PMID: 33401464]
[64]
Rathod SB, Kumbhar SS, Nanivadekar A, Aman K. Role of diffusion-weighted MRI in acute pyelonephritis: a prospective study. Acta radiologica (Stockholm, Sweden : 1987). 2015 Feb:56(2):244-9. doi: 10.1177/0284185114520862. Epub 2014 Jan 17
[PubMed PMID: 24443116]
[65]
Lee A, Kim HC, Hwang SI, Chin HJ, Na KY, Chae DW, Kim S. Clinical Usefulness of Unenhanced Computed Tomography in Patients with Acute Pyelonephritis. Journal of Korean medical science. 2018 Sep 17:33(38):e236. doi: 10.3346/jkms.2018.33.e236. Epub 2018 Aug 1
[PubMed PMID: 30224907]
[66]
Ubee SS, McGlynn L, Fordham M. Emphysematous pyelonephritis. BJU international. 2011 May:107(9):1474-8. doi: 10.1111/j.1464-410X.2010.09660.x. Epub 2010 Sep 14
[PubMed PMID: 20840327]
[68]
Vernuccio F, Patti D, Cannella R, Salvaggio G, Midiri M. CT imaging of acute and chronic pyelonephritis: a practical guide for emergency radiologists. Emergency radiology. 2020 Oct:27(5):561-567. doi: 10.1007/s10140-020-01788-z. Epub 2020 May 22
[PubMed PMID: 32445022]
[69]
Ha SK, Seo JK, Kim SJ, Park SH, Park CH, Lee HY, Han DS, Kim KW. Acute pyelonephritis focusing on perfusion defects on contrast enhanced computerized tomography(CT) scans and its clinical outcome. The Korean journal of internal medicine. 1997 Jun:12(2):122-7
[PubMed PMID: 9439146]
Level 2 (mid-level) evidence
[70]
Mainali A, Adhikari S, Chowdhury T, Gousy N, Uprety N, Arora A, Palencia CJ. Acute Non-Obstructive Bilateral Pyelonephritis With Acute Kidney Injury Requiring Hemodialysis. Cureus. 2022 Jul:14(7):e26746. doi: 10.7759/cureus.26746. Epub 2022 Jul 11
[PubMed PMID: 35967161]
[71]
Guvvala SL, Sakam S, Stokes MB, Uday K. Bilateral acute non-obstructive pyelonephritis presenting as acute kidney injury requiring haemodialysis. BMJ case reports. 2019 Feb 21:12(2):. doi: 10.1136/bcr-2018-227996. Epub 2019 Feb 21
[PubMed PMID: 30796082]
Level 3 (low-level) evidence
[72]
Lee YJ, Cho S, Kim SR. Unilateral and bilateral acute pyelonephritis: differences in clinical presentation, progress and outcome. Postgraduate medical journal. 2014 Feb:90(1060):80-5. doi: 10.1136/postgradmedj-2013-131935. Epub 2013 Nov 19
[PubMed PMID: 24255118]
[73]
Jiao S, Yan Z, Zhang C, Li J, Zhu J. Clinical features of acute focal bacterial nephritis in adults. Scientific reports. 2022 May 4:12(1):7292. doi: 10.1038/s41598-022-10809-5. Epub 2022 May 4
[PubMed PMID: 35508538]
[74]
Rosenfield AT, Glickman MG, Taylor KJ, Crade M, Hodson J. Acute focal bacterial nephritis (acute lobar nephronia). Radiology. 1979 Sep:132(3):553-61
[PubMed PMID: 382239]
[75]
Huang JJ, Sung JM, Chen KW, Ruaan MK, Shu GH, Chuang YC. Acute bacterial nephritis: a clinicoradiologic correlation based on computed tomography. The American journal of medicine. 1992 Sep:93(3):289-98
[PubMed PMID: 1524081]
[76]
Hosokawa T, Tanami Y, Sato Y, Oguma E. Comparison of imaging findings between acute focal bacterial nephritis (acute lobar nephronia) and acute pyelonephritis: a preliminary evaluation of the sufficiency of ultrasound for the diagnosis of acute focal bacterial nephritis. Emergency radiology. 2020 Aug:27(4):405-412. doi: 10.1007/s10140-020-01771-8. Epub 2020 Mar 11
[PubMed PMID: 32162084]
[77]
Patel H, Shekar Paulraj A, Anand B. Thinking of Draining a Renal Abscess? Wait! - Could Be Acute Lobar Nephronia. Urology. 2021 Oct:156():e90-e92. doi: 10.1016/j.urology.2021.07.008. Epub 2021 Jul 22
[PubMed PMID: 34302834]
[78]
Fujita Y, Imataka G, Kuwashima S, Yoshihara S. Magnetic resonance imaging diagnosis of acute focal bacterial nephritis with MERS. Pediatrics international : official journal of the Japan Pediatric Society. 2020 Sep:62(9):1121-1122. doi: 10.1111/ped.14315. Epub
[PubMed PMID: 33000563]
[79]
Yılmaz K, Koç G, Yel S, Dursun İ, Doğanay S. Acute lobar nephronia: value of unique magnetic resonance imaging findings in diagnosis and management. The Turkish journal of pediatrics. 2015 Jan-Feb:57(1):105-8
[PubMed PMID: 26613232]
[80]
Dembry LM, Andriole VT. Renal and perirenal abscesses. Infectious disease clinics of North America. 1997 Sep:11(3):663-80
[PubMed PMID: 9378929]
[81]
Oka H, Nagamori T, Yamamoto S, Manabe H, Taketazu G, Mukai T, Sakata H, Oki J. Non-invasive discrimination of acute focal bacterial nephritis with pyelonephritis. Pediatrics international : official journal of the Japan Pediatric Society. 2019 Aug:61(8):777-780. doi: 10.1111/ped.13910. Epub 2019 Aug 14
[PubMed PMID: 31410918]
[82]
Kline MW, Kaplan SL, Baker CJ. Acute focal bacterial nephritis: diverse clinical presentations in pediatric patients. The Pediatric infectious disease journal. 1988 May:7(5):346-9
[PubMed PMID: 3288948]
[83]
Cheng CH, Tsau YK, Hsu SY, Lee TL. Effective ultrasonographic predictor for the diagnosis of acute lobar nephronia. The Pediatric infectious disease journal. 2004 Jan:23(1):11-4
[PubMed PMID: 14743039]
[84]
Seidel T, Kuwertz-Bröking E, Kaczmarek S, Kirschstein M, Frosch M, Bulla M, Harms E. Acute focal bacterial nephritis in 25 children. Pediatric nephrology (Berlin, Germany). 2007 Nov:22(11):1897-901
[PubMed PMID: 17874139]
[85]
Dubey D, Raza FS, Sawhney A, Pandey A. Klebsiella pneumoniae Renal Abscess Syndrome: A Rare Case with Metastatic Involvement of Lungs, Eye, and Brain. Case reports in infectious diseases. 2013:2013():685346. doi: 10.1155/2013/685346. Epub 2013 Aug 5
[PubMed PMID: 23984128]
Level 3 (low-level) evidence
[86]
Linder BJ, Granberg CF. Pediatric renal abscesses: A contemporary series. Journal of pediatric urology. 2016 Apr:12(2):99.e1-5. doi: 10.1016/j.jpurol.2015.05.037. Epub 2015 Sep 16
[PubMed PMID: 26522771]
[87]
Hodler J, Kubik-Huch RA, von Schulthess GK, Nicola R, Menias CO. Urinary Obstruction, Stone Disease, and Infection. Diseases of the Abdomen and Pelvis 2018-2021: Diagnostic Imaging - IDKD Book. 2018:():
[PubMed PMID: 31314368]
[88]
Tamburrini S, Lugarà M, Iannuzzi M, Cesaro E, De Simone F, Del Biondo D, Toto R, Iulia D, Marrone V, Faella P, Liguori C, Marano I. Pyonephrosis Ultrasound and Computed Tomography Features: A Pictorial Review. Diagnostics (Basel, Switzerland). 2021 Feb 17:11(2):. doi: 10.3390/diagnostics11020331. Epub 2021 Feb 17
[PubMed PMID: 33671431]
[89]
Lee RA, Centor RM, Humphrey LL, Jokela JA, Andrews R, Qaseem A, Scientific Medical Policy Committee of the American College of Physicians, Akl EA, Bledsoe TA, Forciea MA, Haeme R, Kansagara DL, Marcucci M, Miller MC, Obley AJ. Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians. Annals of internal medicine. 2021 Jun:174(6):822-827. doi: 10.7326/M20-7355. Epub 2021 Apr 6
[PubMed PMID: 33819054]
[90]
Ward G, Jorden RC, Severance HW. Treatment of pyelonephritis in an observation unit. Annals of emergency medicine. 1991 Mar:20(3):258-61
[PubMed PMID: 1996820]
[91]
Goodlet KJ, Benhalima FZ, Nailor MD. A Systematic Review of Single-Dose Aminoglycoside Therapy for Urinary Tract Infection: Is It Time To Resurrect an Old Strategy? Antimicrobial agents and chemotherapy. 2019 Jan:63(1):. doi: 10.1128/AAC.02165-18. Epub 2018 Dec 21
[PubMed PMID: 30397061]
Level 1 (high-level) evidence
[93]
Liljedahl Prytz K, Prag M, Fredlund H, Magnuson A, Sundqvist M, Källman J. Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis. PloS one. 2020:15(7):e0236864. doi: 10.1371/journal.pone.0236864. Epub 2020 Jul 30
[PubMed PMID: 32730359]
[94]
Cobussen M, de Kort JM, Dennert RM, Lowe SH, Stassen PM. No increased risk of acute kidney injury after a single dose of gentamicin in patients with sepsis. Infectious diseases (London, England). 2016 Apr:48(4):274-280. doi: 10.3109/23744235.2015.1109136. Epub 2015 Nov 15
[PubMed PMID: 26567531]
[95]
Cobussen M, Haeseker MB, Stoffers J, Wanrooij VHM, Savelkoul PHM, Stassen PM. Renal safety of a single dose of gentamicin in patients with sepsis in the emergency department. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020 Jul 1:():. pii: S1198-743X(20)30376-1. doi: 10.1016/j.cmi.2020.06.030. Epub 2020 Jul 1
[PubMed PMID: 32621972]
[96]
Mohsenpour B, Ahmadi A, Azizzadeh H, Ghaderi E, Hajibagheri K, Afrasiabian S, Lotfi G, Farzinpoor Z. Comparison of three doses of amikacin on alternate days with a daily dose of meropenem during the same period for the treatment of urinary tract infection with E. coli: a double-blind clinical trial. BMC research notes. 2024 Jan 25:17(1):38. doi: 10.1186/s13104-023-06654-y. Epub 2024 Jan 25
[PubMed PMID: 38273327]
Level 1 (high-level) evidence
[97]
Lumbiganon P, Laopaiboon M, Thinkhamrop J. Screening and treating asymptomatic bacteriuria in pregnancy. Current opinion in obstetrics & gynecology. 2010 Apr:22(2):95-9. doi: 10.1097/GCO.0b013e3283374adf. Epub
[PubMed PMID: 20139763]
Level 3 (low-level) evidence
[98]
Haas CR, Li G, Hyams ES, Shah O. Delayed Decompression of Obstructing Stones with Urinary Tract Infection is Associated with Increased Odds of Death. The Journal of urology. 2020 Dec:204(6):1256-1262. doi: 10.1097/JU.0000000000001182. Epub 2020 Jun 5
[PubMed PMID: 32501124]
[99]
Vouloumanou EK, Rafailidis PI, Kazantzi MS, Athanasiou S, Falagas ME. Early switch to oral versus intravenous antimicrobial treatment for hospitalized patients with acute pyelonephritis: a systematic review of randomized controlled trials. Current medical research and opinion. 2008 Dec:24(12):3423-34. doi: 10.1185/03007990802550679. Epub
[PubMed PMID: 19032124]
Level 1 (high-level) evidence
[101]
Padberg S, Wacker E, Meister R, Panse M, Weber-Schoendorfer C, Oppermann M, Schaefer C. Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones. Antimicrobial agents and chemotherapy. 2014 Aug:58(8):4392-8. doi: 10.1128/AAC.02413-14. Epub 2014 May 19
[PubMed PMID: 24841264]
[102]
Yefet E, Schwartz N, Chazan B, Salim R, Romano S, Nachum Z. The safety of quinolones and fluoroquinolones in pregnancy: a meta-analysis. BJOG : an international journal of obstetrics and gynaecology. 2018 Aug:125(9):1069-1076. doi: 10.1111/1471-0528.15119. Epub 2018 Feb 22
[PubMed PMID: 29319210]
Level 1 (high-level) evidence
[103]
Jolley JA, Wing DA. Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes. Drugs. 2010 Sep 10:70(13):1643-55. doi: 10.2165/11538050-000000000-00000. Epub
[PubMed PMID: 20731473]
[104]
Kyriazopoulou E, Liaskou-Antoniou L, Adamis G, Panagaki A, Melachroinopoulos N, Drakou E, Marousis K, Chrysos G, Spyrou A, Alexiou N, Symbardi S, Alexiou Z, Lagou S, Kolonia V, Gkavogianni T, Kyprianou M, Anagnostopoulos I, Poulakou G, Lada M, Makina A, Roulia E, Koupetori M, Apostolopoulos V, Petrou D, Nitsotolis T, Antoniadou A, Giamarellos-Bourboulis EJ. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial. American journal of respiratory and critical care medicine. 2021 Jan 15:203(2):202-210. doi: 10.1164/rccm.202004-1201OC. Epub
[PubMed PMID: 32757963]
Level 1 (high-level) evidence
[105]
Ribeiro VST, Bail L, Ito CAS, Andrade AP, Arend LNVS, Suss PH, Nogueira KDS, Walflor HSM, Faoro H, Kuczera LCSM, Vicenzi FJ, Tuon FF. In vitro susceptibility to fosfomycin in clinical and environmental extended-spectrum beta-lactamase producing and/or ciprofloxacin-non-susceptible Escherichia coli isolates. Revista do Instituto de Medicina Tropical de Sao Paulo. 2024:66():e5. doi: 10.1590/S1678-9946202466005. Epub 2024 Feb 5
[PubMed PMID: 38324871]
[106]
Bilal M, El Tabei L, Büsker S, Krauss C, Fuhr U, Taubert M. Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol. Clinical pharmacokinetics. 2021 Dec:60(12):1495-1508. doi: 10.1007/s40262-021-01063-5. Epub 2021 Aug 22
[PubMed PMID: 34420182]
[107]
Hatlen TJ, Flor R, Nguyen MH, Lee GH, Miller LG. Oral fosfomycin use for pyelonephritis and complicated urinary tract infections: a 1 year review of outcomes and prescribing habits in a large municipal healthcare system. The Journal of antimicrobial chemotherapy. 2020 Jul 1:75(7):1993-1997. doi: 10.1093/jac/dkaa126. Epub
[PubMed PMID: 32303061]
[108]
Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Alvarez RM, Dueñas CJ, Calvo-Montes J, Silva JT, Cárdenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yagüe-Guirao G, Lobo-Acosta MA, Merino-Bohórquez V, Pascual A, Rodríguez-Baño J, REIPI-GEIRAS-FOREST group. Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial. JAMA network open. 2022 Jan 4:5(1):e2137277. doi: 10.1001/jamanetworkopen.2021.37277. Epub 2022 Jan 4
[PubMed PMID: 35024838]
Level 1 (high-level) evidence
[109]
Kaye KS, Rice LB, Dane AL, Stus V, Sagan O, Fedosiuk E, Das AF, Skarinsky D, Eckburg PB, Ellis-Grosse EJ. Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019 Nov 27:69(12):2045-2056. doi: 10.1093/cid/ciz181. Epub
[PubMed PMID: 30861061]
Level 1 (high-level) evidence
[110]
Pipitone G, Di Bella S, Maraolo AE, Granata G, Gatti M, Principe L, Russo A, Gizzi A, Pallone R, Cascio A, Iaria C. Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections. Antibiotics (Basel, Switzerland). 2023 Nov 23:12(12):. doi: 10.3390/antibiotics12121653. Epub 2023 Nov 23
[PubMed PMID: 38136687]
[111]
Burgos RM, Rodvold KA. ZTI-01 (fosfomycin for injection) in the treatment of hospitalized patients with complicated urinary tract infections. Future microbiology. 2019 Apr:14():461-475. doi: 10.2217/fmb-2018-0303. Epub 2019 Mar 11
[PubMed PMID: 30854892]
[112]
Wald-Dickler N, Lee TC, Tangpraphaphorn S, Butler-Wu SM, Wang N, Degener T, Kan C, Phillips MC, Cho E, Canamar C, Holtom P, Spellberg B. Fosfomycin vs Ertapenem for Outpatient Treatment of Complicated Urinary Tract Infections: A Multicenter, Retrospective Cohort Study. Open forum infectious diseases. 2022 Jan:9(1):ofab620. doi: 10.1093/ofid/ofab620. Epub 2021 Dec 23
[PubMed PMID: 35036466]
Level 2 (mid-level) evidence
[113]
Sojo-Dorado J, López-Hernández I, Hernández-Torres A, Retamar-Gentil P, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Álvarez RM, Dueñas CJ, Calvo-Montes J, Lecuona M, Pomar V, Borreguero I, Palomo-Jiménez V, Docobo-Pérez F, Pascual Á, Rodríguez-Baño J. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial. The Journal of antimicrobial chemotherapy. 2023 Jul 5:78(7):1658-1666. doi: 10.1093/jac/dkad147. Epub
[PubMed PMID: 37260299]
Level 1 (high-level) evidence
[114]
Souza RB, Trevisol DJ, Schuelter-Trevisol F. Bacterial sensitivity to fosfomycin in pregnant women with urinary infection. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2015 May-Jun:19(3):319-23. doi: 10.1016/j.bjid.2014.12.009. Epub 2015 Jan 24
[PubMed PMID: 25626961]
[117]
Elbaz M, Zadka H, Weiss-Meilik A, Ben-Ami R. Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritis. The Journal of antimicrobial chemotherapy. 2020 Aug 1:75(8):2307-2313. doi: 10.1093/jac/dkaa148. Epub
[PubMed PMID: 32451549]
[118]
Zohar I, Schwartz O, Yossepowitch O, David SSB, Maor Y. Aminoglycoside versus carbapenem or piperacillin/tazobactam treatment for bloodstream infections of urinary source caused by Gram-negative ESBL-producing Enterobacteriaceae. The Journal of antimicrobial chemotherapy. 2020 Feb 1:75(2):458-465. doi: 10.1093/jac/dkz457. Epub
[PubMed PMID: 31691817]
[119]
Frimodt-Møller N, Bjerrum L. Treating urinary tract infections in the era of antibiotic resistance. Expert review of anti-infective therapy. 2023 Jul-Dec:21(12):1301-1308. doi: 10.1080/14787210.2023.2279104. Epub 2023 Nov 24
[PubMed PMID: 37922147]
[120]
Titelman E, Iversen A, Kalin M, Giske CG. Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Microbial drug resistance (Larchmont, N.Y.). 2012 Apr:18(2):189-92. doi: 10.1089/mdr.2011.0161. Epub 2011 Dec 28
[PubMed PMID: 22204597]
[121]
Nicolle LE. Pivmecillinam in the treatment of urinary tract infections. The Journal of antimicrobial chemotherapy. 2000 Sep:46 Suppl 1():35-9; discussion 63-5
[PubMed PMID: 11051622]
[122]
Kresken M, Pfeifer Y, Wagenlehner F, Werner G, Wohlfarth E, Therapy OBOSG'ROTPESFI. Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in Escherichia coli Isolated from Urine Specimens of Primary Care Patients in Germany, 2019/20. Antibiotics (Basel, Switzerland). 2022 May 31:11(6):. doi: 10.3390/antibiotics11060751. Epub 2022 May 31
[PubMed PMID: 35740157]
[123]
Hansen BÅ, Grude N, Lindbæk M, Stenstad T. The efficacy of pivmecillinam in oral step-down treatment in hospitalised patients with E. coli bacteremic urinary tract infection; a single-arm, uncontrolled treatment study. BMC infectious diseases. 2022 May 19:22(1):478. doi: 10.1186/s12879-022-07463-7. Epub 2022 May 19
[PubMed PMID: 35590284]
[124]
Graninger W. Pivmecillinam--therapy of choice for lower urinary tract infection. International journal of antimicrobial agents. 2003 Oct:22 Suppl 2():73-8
[PubMed PMID: 14527775]
[125]
Bethel J. Acute pyelonephritis: risk factors, diagnosis and treatment. Nursing standard (Royal College of Nursing (Great Britain) : 1987). 2012 Oct 3-9:27(5):51-6; quiz 58
[PubMed PMID: 23256302]
[126]
Husain S, Alroumoh M, Mohan P, El-Kass G, Seshan SV, Galler M. Acute kidney injury from pyelonephritis in an elderly man: case report. International urology and nephrology. 2011 Sep:43(3):925-8. doi: 10.1007/s11255-011-0019-6. Epub 2011 Jul 8
[PubMed PMID: 21739178]
Level 3 (low-level) evidence
[127]
De Nunzio C, Bartoletti R, Tubaro A, Simonato A, Ficarra V. Role of D-Mannose in the Prevention of Recurrent Uncomplicated Cystitis: State of the Art and Future Perspectives. Antibiotics (Basel, Switzerland). 2021 Apr 1:10(4):. doi: 10.3390/antibiotics10040373. Epub 2021 Apr 1
[PubMed PMID: 33915821]
Level 3 (low-level) evidence
[128]
Chung VY, Tai CK, Fan CW, Tang CN. Severe acute pyelonephritis: a review of clinical outcome and risk factors for mortality. Hong Kong medical journal = Xianggang yi xue za zhi. 2014 Aug:20(4):285-9. doi: 10.12809/hkmj134061. Epub 2014 Mar 14
[PubMed PMID: 24625386]
Level 2 (mid-level) evidence
[129]
Shields J, Maxwell AP. Acute pyelonephritis can have serious complications. The Practitioner. 2010 Apr:254(1728):19, 21, 23-4, 2
[PubMed PMID: 20486480]
[130]
Stone SC, Mallon WK, Childs JM, Docherty SD. Emphysematous pyelonephritis: clues to rapid diagnosis in the Emergency Department. The Journal of emergency medicine. 2005 Apr:28(3):315-319. doi: 10.1016/j.jemermed.2004.07.015. Epub
[PubMed PMID: 15769576]
[132]
Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. The Journal of infectious diseases. 2001 Mar 1:183 Suppl 1():S1-4
[PubMed PMID: 11171002]
[133]
Saul H, Deeney B, Cassidy S, Kwint J, Harding C. Methenamine is as effective as antibiotics at preventing urinary tract infections. BMJ (Clinical research ed.). 2023 Jan 17:380():72. doi: 10.1136/bmj.p72. Epub 2023 Jan 17
[PubMed PMID: 36649970]
[134]
Harding C, Chadwick T, Homer T, Lecouturier J, Mossop H, Carnell S, King W, Abouhajar A, Vale L, Watson G, Forbes R, Currer S, Pickard R, Eardley I, Pearce I, Thiruchelvam N, Guerrero K, Walton K, Hussain Z, Lazarowicz H, Ali A. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT. Health technology assessment (Winchester, England). 2022 May:26(23):1-172. doi: 10.3310/QOIZ6538. Epub
[PubMed PMID: 35535708]
[135]
Harding C, Mossop H, Homer T, Chadwick T, King W, Carnell S, Lecouturier J, Abouhajar A, Vale L, Watson G, Forbes R, Currer S, Pickard R, Eardley I, Pearce I, Thiruchelvam N, Guerrero K, Walton K, Hussain Z, Lazarowicz H, Ali A. Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial. BMJ (Clinical research ed.). 2022 Mar 9:376():e068229. doi: 10.1136/bmj-2021-0068229. Epub 2022 Mar 9
[PubMed PMID: 35264408]
Level 1 (high-level) evidence
[136]
Harris E. Updated Meta-analysis: Cranberry Products Reduced UTI Risk. JAMA. 2023 May 23:329(20):1730. doi: 10.1001/jama.2023.7761. Epub
[PubMed PMID: 37133890]
Level 1 (high-level) evidence
[137]
Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. The Cochrane database of systematic reviews. 2012 Oct 17:10(10):CD001321. doi: 10.1002/14651858.CD001321.pub5. Epub 2012 Oct 17
[PubMed PMID: 23076891]
Level 1 (high-level) evidence
[138]
Caretto M, Giannini A, Russo E, Simoncini T. Preventing urinary tract infections after menopause without antibiotics. Maturitas. 2017 May:99():43-46. doi: 10.1016/j.maturitas.2017.02.004. Epub 2017 Feb 7
[PubMed PMID: 28364867]
[139]
Lenger SM, Chu CM, Ghetti C, Durkin MJ, Jennings Z, Wan F, Sutcliffe S, Lowder JL. d-Mannose for Recurrent Urinary Tract Infection Prevention in Postmenopausal Women Using Vaginal Estrogen: A Randomized Controlled Trial. Urogynecology (Philadelphia, Pa.). 2023 Mar 1:29(3):367-377. doi: 10.1097/SPV.0000000000001270. Epub 2022 Oct 15
[PubMed PMID: 36808931]
Level 1 (high-level) evidence
[140]
Salvatore S, Ruffolo AF, Stabile G, Casiraghi A, Zito G, De Seta F. A Randomized Controlled Trial Comparing a New D-Mannose-based Dietary Supplement to Placebo for the Treatment of Uncomplicated Escherichia coli Urinary Tract Infections. European urology focus. 2023 Jul:9(4):654-659. doi: 10.1016/j.euf.2022.12.013. Epub 2023 Jan 6
[PubMed PMID: 36621376]
Level 1 (high-level) evidence